Save time and get answers to complex questions with AI chat
Alogliptin benzoate cost?Mebendazole ingredients?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Tenofovir generic patent?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Ertapenem
Ertapenem (brand name Invanz) received its first regulatory approval in the United States on December 26, 2001 [1].
No. The date above is for the U.S. license/approval. If you need the first worldwide approval date (for example, in the EU or another country), tell me which country/agency you mean (FDA, EMA, MHRA, etc.), and I can map the correct “licensed date” for that jurisdiction.
For medicines, “licensed date” commonly means the date the drug received its marketing authorization (approval/licensing) from a regulator, such as the FDA approval date for the initial U.S. product label [1]. Sources: [1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050571s032lbl.pdf
Other Questions About Ertapenem :